Wireless Fetal Monitoring System Market By Product Offering (Wearable/Patch-Based Systems, Cableless Telemetry & Monitoring Hardware, Software & Data Analytics Platforms); By Application (Routine Fetal Monitoring, High-Risk Pregnancy Monitoring, Peripartum & Transition Monitoring, Other Applications); By End User (Hospitals, Obstetric & MFM Clinics, Home & Remote Monitoring Programs, Research Organizations); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

What Is the Wireless Fetal Monitoring System Market Size and What Technology Developments Are Shaping Its Growth? – (Updated On: 28-Aug-2026)

The Global Wireless Fetal Monitoring System Market was valued at USD 1.91 billion in 2025 and is projected to reach USD 3.19 billion by 2032, expanding at a CAGR of 7.6% during 2026–2032, according to Strategic Market Research.

 

Wireless fetal monitoring systems use cableless transducers, wearable patches and connected software to track fetal heart rate, maternal heart rate and uterine activity without tethering the patient to a bedside monitor. Principal settings are labor-and-delivery units, antepartum departments, maternal-fetal medicine clinics and selected remote non-stress-test programs. This report includes wireless ultrasound/TOCO telemetry, beltless electrophysiological patches, compatible hardware and directly attributable software; wired-only fetal monitors, consumer Dopplers and neonatal monitors are excluded.

 

New wireless fetal monitoring systems use belt-free adhesive patches and Bluetooth connectivity to continuously track fetal heart rate, maternal heart rate, and uterine contractions while allowing greater patient mobility. Platforms such as GE HealthCare’s Novii+ replace conventional elastic belts with abdominal electrodes, enabling patients to walk, change positions, use birthing balls, or shower during labor. Advanced systems also use fetal ECG and uterine EMG signals, while platforms such as Nuvo’s INVU incorporate AI-supported remote monitoring and non-stress testing.

 

What Are the Key Wireless Fetal Monitoring System Market Takeaways?

By Product Offering

• Wearable/Patch-Based Systems: 31.0% | USD 0.592 billion | 9.2% CAGR. Beltless patches combine mobility with recurring single-patient consumables.

• Cableless Telemetry & Monitoring Hardware: 55.0% | USD 1.051 billion | 5.8% CAGR. Installed monitor fleets and reusable ultrasound/TOCO transducers support the largest category.

• Software & Data Analytics Platforms: 14.0% | USD 0.267 billion | 10.5% CAGR. Central surveillance, WLAN connectivity, EMR integration and remote monitoring support faster expansion.

 

By Application

• Routine Fetal Monitoring: 51.0% | USD 0.974 billion | 6.4% CAGR. Routine antepartum and intrapartum surveillance provides the largest workload.

• High-Risk Pregnancy Monitoring: 34.0% | USD 0.649 billion | 9.3% CAGR. Longer monitoring and difficult signal acquisition support above-market growth.

• Peripartum & Transition Monitoring: 8.0% | USD 0.153 billion | 8.4% CAGR. This reframed category covers integrated monitoring around delivery and immediate care transition, not fetal monitoring after birth.

• Other Applications: 7.0% | USD 0.134 billion | 6.2% CAGR. Specialist programs and research form the remaining market.

 

By End User

• Hospitals: 64.0% | USD 1.222 billion | 6.9% CAGR. Labor-and-delivery units control most monitoring infrastructure.

• Obstetric & MFM Clinics: 18.0% | USD 0.344 billion | 7.2% CAGR. Outpatient assessment and NST use support this segment.

• Home & Remote Monitoring Programs: 13.0% | USD 0.248 billion | 11.0% CAGR. Prescribed remote NST models make this the fastest-growing end-user category.

• Research Organizations: 5.0% | USD 0.096 billion | 7.8% CAGR. Clinical validation supports a smaller specialist market.

 

By Region

• North America: 40.0% | USD 0.764 billion | 6.9% CAGR.

• Europe: 28.0% | USD 0.535 billion | 6.8% CAGR.

• Asia-Pacific: 23.0% | USD 0.439 billion | 9.7% CAGR.

• Latin America: 5.0% | USD 0.096 billion | 7.8% CAGR.

• Middle East & Africa: 4.0% | USD 0.076 billion | 7.2% CAGR.

 

How Is the Wireless Fetal Monitoring System Market Defined Commercially?

SMR treats this as a monitoring-device and workflow market rather than a disease-treatment market. Revenue comes from monitors, receivers, telemetry transducers and pods; single-patient patches and electrodes; and software/connectivity directly tied to fetal monitoring. The key commercial models are installed-base telemetry, patch-enabled monitoring and connected or remote monitoring.

Births establish the broad patient base, but revenue is more directly influenced by CTG/NST utilization, high-risk monitoring intensity, replacement cycles, wireless penetration, disposable use and compatibility with existing monitor fleets.

 

Which Product Offerings Are Reshaping the Wireless Fetal Monitoring System Market?

Wearable/Patch-Based Systems accounted for 31.0% of the market, or USD 0.592 billion in 2025, and are projected to expand at 9.2%. GE Novii+ captures fECG, mECG and uterine EMG through peel-and-stick electrodes and sends processed data to compatible Corometrics monitors. Philips Avalon Beltless similarly derives fetal and maternal heart rates and uterine activity from abdominal ECG/EMG. NICE’s Novii briefing summarized six studies involving 487 women and found performance comparable with standard monitoring, with potential advantages in higher-BMI patients, while noting evidence limitations.[7-9]

Cableless Telemetry & Monitoring Hardware held 55.0%, representing USD 1.051 billion in 2025, with a 5.8% CAGR. GE Mini Telemetry uses waterproof Nautilus transducers with Corometrics monitors; Philips Avalon CL extends cableless monitoring over hospital WLAN; Huntleigh’s Sonicaid Team3 supports wireless transducers; and EDAN’s FTS-3 provides cordless waterproof ultrasound monitoring, including twins. These systems add mobility without replacing the core monitoring method.[10-13]

Software & Data Analytics Platforms accounted for 14.0%, or USD 0.267 billion, and are projected to grow at 10.5%. Connectivity matters because fetal traces increasingly flow to central surveillance, archival systems and electronic records. Philips, for example, links Avalon cableless measurements with IntelliSpace Perinatal and uses WLAN to extend monitoring range.[11]

 

Which Applications and Care Settings Matter Most?

Routine Fetal Monitoring represented 51.0% of the market, or USD 0.974 billion in 2025, and is projected to grow at 6.4%. Antepartum testing and intrapartum CTG are established workflows, and wireless technology adds mobility while preserving continuous surveillance.

High-Risk Pregnancy Monitoring accounted for 34.0%, or USD 0.649 billion, with a 9.3% CAGR. NICE recommends continuous CTG in labor for multiple maternal and fetal risk situations, while 10.41% of U.S. births were preterm in 2024. Longer surveillance and difficult signal acquisition make this a strategic use case.[2,6]

Peripartum & Transition Monitoring represented 8.0%, or USD 0.153 billion, and is projected to grow at 8.4%. It captures integrated perinatal hardware/software used around delivery and immediate care transition. Fetal heart-rate monitoring ends at birth; unrelated post-delivery maternal or neonatal monitoring is outside the market.

Other Applications held 7.0%, or USD 0.134 billion, with a 6.2% CAGR, covering research and specialist obstetric programs.

Hospitals accounted for 64.0%, or USD 1.222 billion, and are projected to expand at 6.9%. Their position reflects labor-and-delivery infrastructure and replacement cycles. Bradford Teaching Hospitals awarded Huntleigh a £18,840 contract in February 2026 for two fetal monitors to complement existing equipment and replace aging systems; Northumbria Healthcare separately procured a Sonicaid Team3 Twins Wireless Transducer System for about £49,313 in 2026.[14-15]

Obstetric & MFM Clinics held 18.0%, or USD 0.344 billion, with a 7.2% CAGR. Home & Remote Monitoring Programs represented 13.0%, or USD 0.248 billion, and lead growth at 11.0%. Philips currently markets an INVU-based, FDA-cleared solution for prescribed remote NSTs. March of Dimes identified 1,104 U.S. maternity-care-desert counties housing more than 2.3 million women of reproductive age and accounting for more than 150,000 births in 2022, supporting the access rationale for selected remote surveillance.[16-17] Research Organizations accounted for 5.0%, or USD 0.096 billion, with a 7.8% CAGR.

 

How Do Procurement, Consumables and Workflow Affect Market Economics?

Wireless fetal monitoring is primarily financed through hospital capital budgets, maternity-service spending and recurring consumables rather than a dedicated reimbursement code for the wireless device. Patch systems add recurring revenue per patient, while reusable telemetry has a lower disposable burden but depends heavily on the installed monitor ecosystem.

NICE’s 2020 Novii briefing provides a historical NHS benchmark: £4,995 for the system, about £35 per patient for the patch and £6,600 for a compatible Corometrics 259cx monitor if not already installed, versus about £7,000 for standard CTG equipment plus roughly £30 per patient in associated consumables. These are not current prices, but they show why installed-base compatibility affects total cost.[7]

NICE’s guidance on unresolved wireless signal loss also means hospitals evaluate battery readiness, charging, cleaning, network coverage, trace continuity, staff training and wired backup alongside mobility.[6]

 

How Is the Wireless Fetal Monitoring System Market Developing by Region?

North America held 40.0% of the market, worth USD 0.764 billion in 2025, and is projected to grow at 6.9%. The U.S. combines 3.61 million provisional births in 2025 with large hospital monitor fleets and recent FDA activity in beltless systems. Canada recorded 365,737 live births in 2024, up 3.7%. GE, Philips and remote INVU workflows provide multiple commercialization routes.[1,18]

Europe accounted for 28.0%, or USD 0.535 billion, with a 6.8% CAGR. England and Wales recorded 594,677 live births in 2024, Germany 677,117 and France 660,787. With births declining in Germany and France, replacement, wireless penetration and workflow improvement matter more than population expansion. NICE guidance and 2026 NHS procurement provide direct evidence of active institutional purchasing.[14-15,19-21]

Asia-Pacific represented 23.0%, or USD 0.439 billion, and has the fastest regional CAGR at 9.7%. China reported 9.54 million births in 2024, while Australia registered 292,318. The opportunity is concentrated in tertiary maternity hospitals and obstetric networks able to support central surveillance and wireless infrastructure.[22-23]

Latin America accounted for 5.0%, or USD 0.096 billion, with a 7.8% CAGR. Larger public referral hospitals and private maternity facilities are the principal addressable settings; reusable telemetry can lower the consumable burden where budgets constrain patch-based adoption.

Middle East & Africa held 4.0%, or USD 0.076 billion, and is projected to expand at 7.2%. Premium maternity hospitals in Gulf markets are the clearest setting for advanced systems, while lower-resource markets remain more sensitive to core monitor availability, reusable equipment economics and service support.

 

Which Companies Are Best Positioned in the Wireless Fetal Monitoring System Market?

Competition centers on sensing technology, signal continuity, installed-base compatibility, disposable economics, connectivity and expansion beyond the labor room.

GE HealthCare
GE HealthCare has a dual-model position through Novii+ and Mini Telemetry. Novii+ creates recurring patch revenue through abdominal electrophysiological sensing, while Mini Telemetry supports reusable ultrasound/TOCO within Corometrics. K254036, cleared in August 2026, confirms continued Novii+ regulatory iteration.[4,8,10]

Philips
Philips competes through Avalon CL, Avalon Beltless, Wide Range Pod, IntelliSpace Perinatal and an INVU-based Remote Fetal Monitoring solution, covering reusable telemetry, beltless patches, surveillance and remote NST workflows.[5,9,11,16]

Huntleigh Healthcare
Huntleigh Healthcare focuses on Sonicaid Team3 and wireless transducers; its recent NHS awards support continued institutional relevance.[12,14-15]

Nemo Healthcare
Nemo Healthcare uses a six-electrode patch measuring fetal ECG, maternal heart rate and uterine EMG. The company states its system can monitor from 21 weeks until delivery and connect with existing hospital infrastructure.[24]

EDAN Instruments
EDAN’s FTS-3 provides wireless waterproof ultrasound transducers, twin fetal heart-rate monitoring and uterine activity measurement, positioning it around reusable conventional telemetry.[13]

Remote monitoring also carries vendor-continuity risk. Holdco Nuvo filed for Chapter 11 in August 2024, yet Philips continues to market an INVU-based remote solution in 2026. Buyers therefore need to evaluate platform ownership, support and integration continuity.[16,25]

 

What Will Determine Wireless Fetal Monitoring System Market Leadership Through 2032?

The market is developing around installed-base telemetry, patch-enabled monitoring and connected remote surveillance. Established manufacturers benefit from monitor compatibility and switching costs, while patches create recurring consumable revenue and address mobility, BMI-related signal challenges and repositioning.

The fastest supplied growth rates—software at 10.5%, home/remote programs at 11.0%, wearable systems at 9.2% and high-risk monitoring at 9.3%—point toward more connected and less tethered surveillance. Key constraints remain signal continuity, patch cost, interoperability, staff workflow, network reliability and remote-care reimbursement. For executive planning, wireless penetration per maternity unit, replacement cycles, disposable utilization, remote NST adoption and ecosystem lock-in are more useful indicators than birth growth alone.

 

Wireless Fetal Monitoring System Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 1.91 Billion
Revenue Forecast in 2032	USD 3.19 Billion
Overall Growth Rate	CAGR of 7.6% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Billion, CAGR (2026 – 2032)
Segmentation	By Product Offering, By Application, By End User, By Geography
By Product Offering	Wearable/Patch-Based Systems, Cableless Telemetry & Monitoring Hardware, Software & Data Analytics Platforms
By Application	Routine Fetal Monitoring, High-Risk Pregnancy Monitoring, Peripartum & Transition Monitoring, Other Applications
By End User	Hospitals, Obstetric & MFM Clinics, Home & Remote Monitoring Programs, Research Organizations
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Demand for patient mobility during labor, adoption of beltless monitoring patches, growth in high-risk pregnancy surveillance, replacement of hospital monitoring systems, recurring patch consumables, remote NST expansion, and integration with central surveillance and electronic records
Customization Option	Available upon request